Publications Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization Citation Crowley E, Griffiths AM, Jairath V; pIBD CLINICAL TRIALS OUTCOME GROUP. Heterogeneity in Efficacy and Safety Endpoints for Pediatric Clinical Trials in Inflammatory Bowel Disease: A Need for Harmonization. Gastroenterology. 2022 Nov;163(5):1137-1144. doi: 10.1053/j.gastro.2022.07.006. Epub 2022 Jul 16. PMID: 35850191. Tags Clinical Trials, Diagnosis, Drug Therapy, IBD, Inflammatory Bowel Disease, Pediatrics Read More